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Outbreak of Infection with Klebsiella pneumoniae Sequence Type 258 Producing
Klebsiella pneumoniae Carbapenemase 3 in an Intensive Care Unit in Italy
Gram-negative pathogens producing carbapenemases repre-
sent an alarming clinical threat with serious effects on patient
outcomes (3, 7). In 2001, Yigit et al. (11) reported a novel
-lactamase termed “Klebsiella pneumoniae carbapenemase”
(KPC-1) in North Carolina. KPC-producing strains are now
emerging worldwide (5, 6, 8, 9). We report here an outbreak of
infection and colonization with KPC-producing K. pneumoniae
(KPC-Kp) occurring in Palermo, Italy.
Between 9 April and 1 September 2009, 13 inpatients who
had been admitted at the second intensive care unit (ICU),
ARNAS Civico and Benfratelli General Hospital of Palermo,
Italy, were infected or colonized by a carbapenem-resistant K.
pneumoniae isolate (Table 1). The ICU is a 10-bed medical-
surgical unit with approximately 430 admissions per year. Pre-
existing medical or surgical conditions were present in 50%
approximately of all admissions. Organ failure was the leading
cause of admission (70%), followed by monitoring/weaning
from mechanical ventilation (30%). The mean simplified acute
physiology score (SAPS) of ICU patients was 39. ICU mortal-
ity was 24%. Nurse-to-patient ratio was 1:2. Ten out of the 13
patients were infected and five died, with the KPC-Kp infec-
tion being identified as a contributing factor. Five patients
were transferred to other care units of the same hospital, but
two moved to an external rehabilitation unit. All infections
appeared to be nosocomially acquired based upon their onset
compared to ICU admission day of the 10 patients. However,
it was not possible to rule out the possibility that the index
patient could have been colonized at the time of admission,
because active surveillance cultures were not being routinely
performed at the beginning of the outbreak.
Infection control measures, including undertaking contact
precautions, grouping infected/colonized patients into cohorts,
and using dedicated staff and equipment as much as possible,
were implemented as indicated by the Centers for Disease
Control and Prevention (CDC) guidelines for control of infec-
tion with carbapenem-resistant or carbapenemase-producing
Enterobacteriaceae in acute care facilities (1). Active-surveil-
lance rectal cultures were collected at admission and then on a
weekly basis from all patients staying in the ICU more than
48 h. Microbiology records of the ICU for the preceding 12
months were reviewed, but carbapenem-nonsusceptible K.
pneumoniae or other Enterobacteriaceae had not been previ-
ously detected. The outbreak was eventually controlled by Sep-
tember 2009.
Thirty-three isolates showing reduced susceptibility to ertap-
enem (i.e., MIC of 4 mg/liter) were collected from the 13
patients, predominantly from respiratory secretions and blood.
Identification (ID) and antimicrobial susceptibility testing
(AST) were routinely performed using the Vitek-2 system (bio-
Me´rieux, France). The 33 KPC-Kp strains were resistant to
imipenem (MICs, 16 g/ml), meropenem (MICs, 32 g/ml),
and ertapenem (MICs, 8 g/ml). They were also resistant to
amikacin (MICs, 64 g/ml), amoxicillin-clavulanic acid
(MICs, 32 g/ml), cefepime (MICs, 8 g/ml), cefotaxime
(MICs, 8 g/ml), ceftazidime (MICs, 64 g/ml), ciprofloxa-
cin (MICs, 4 g/ml), levofloxacin (MICs, 8 g/ml), pip-
eracillin-tazobactam (MICs, 128 g/ml), tobramycin (MICs,
16 g/ml), and trimethoprim-sulfamethoxazole (MICs,320
g/ml). They were susceptible to gentamicin (MICs, 4 g/ml)
and colistin (MICs, 0.5 g/ml) but showed full or interme-
diate susceptibility to tigecycline (MICs, 4 g/ml).
XbaI pulsed-field gel electrophoresis (PFGE) typing attrib-
uted the 33 KPC-Kp isolates to three closely related pulsotypes
differing from each other by one to three bands. All isolates
were positive for the presence of the KPC, TEM, and SHV
sequences by PCR amplification while testing negative for the
TABLE 1. Clinical characteristics and outcomes of patients with infection or colonization by KPC-producing Klebsiella pneumoniaea
Patient
no.
Age (yr)/
gender
Date of
admission
Cause(s) of
admission
Site(s) or type(s) of
infection/colonization
Rectal
colonization
Empirical
treatmentb
Antimicrobial
therapy after
ID/ASTb
Length of
stay
(days)
Patient outcome
1 67/F April 9 RF, C UTI Present BSC GEN 110 Transferred to the respiratory ICU
2 69/F June 13 MT Sputum, BSI Present TZP COL NAc Alive and still in ICU at the end of
the study period
3 57/M June 15 PT Sputum, BSI Not tested TZP COL 45 Transferred to the thoracic surgery
unit
4 17/M June 25 RF, C Sputum, BSI Present BSC COL 30 Transferred to an external
neurorehabilitation unit
5 81/M June 27 HF, RF UTI Present Not done GEN 30 Death
6 55/M July 10 HT Rectum Present BSC Not done 25 Transferred to the neurology ward
7 67/F July 24 HF, RF Sputum, BSI Present TZP COL 28 Transferred to the respiratory ICU
8 35/F July 24 SS Peritonitis Not tested Not done COL 2 Death
9 63/F July 31 IH UTI Not tested BSC GEN 52 Transferred to the neurology ward
10 78/F August 8 HF, RF Nares (colonized) Not tested Not done Not done 20 Death
11 68/M August 13 PT Rectum Present BSC Not done 16 Death
12 45/M August 27 PT Peritonitis Not tested TZP COL 33 Transferred to an external
neurorehabilitation unit
13 66/F September 1 SS Peritonitis, BSI Not tested Not done COL 9 Death
a Abbreviations: F, female; M, male; C, coma; RF, respiratory failure; MT, medullary trauma; PT, polytrauma; HF, heart failure; HT, head trauma; SS, septic shock;
IH, intracranial hemorrhage; UTI, urinary tract infection; BSI, bloodstream infection; BSC, broad-spectrum cephalosporin; COL, colistin; GEN, gentamicin; TZP,
tazobactam-piperacillin.
b Only antibiotic treatments for Gram-negative bacteria were considered.
c NA, not available, because the patient was still in the ICU at the end of the study.
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VIM, IMP, and qnr genes (10). Previously described primers
were also used to amplify an 851-bp fragment containing the
waaE gene (10). Sequencing of all amplicons obtained from
three representative isolates, which had been selected on the
basis of variation in PFGE pattern, revealed that blaKPC-3,
blaTEM-1, and blaSHV-11 were present. In comparison with a
reference sequence (GenBank accession number AF146532),
the waaE sequence contained five nucleotide changes: four
were silent, but one was predicted to determine an Arg (48)3
Gly substitution. The substitution is different than that ob-
served by Woodford et al. (10) in isolates from ICUs in New
York—Ile (31) 3 Val—and thus could likely be useful as an
epidemiological strain marker. Multilocus sequence typing
(MLST) was performed according to the protocol described on
the K. pneumoniae MLST website (http://www.pasteur.fr
/recherche/genopole/PF8/mlst/Kpneumoniae.html) (2) and at-
tributed the three representative isolates to sequence type 258
(ST258).
This study reports for the first time an outbreak of KPC-Kp
infection and colonization in an ICU in Italy. Indeed, only one
case of infection in an inpatient, at the University Hospital of
Florence, has been previously reported in Italy (4). The char-
acteristics of our strains are consistent with isolates from sev-
eral geographic areas, such as the United States and Israel (5,
6). Clone ST258 has been shown to account for approximately
70% of the KPC-Kp strains sent to the CDC (5). In Europe, it
has also been found in Norway, Sweden, and Finland from
patients transferred from Greece, Israel, and Italy (8, 9).
There is need of urgent action to be undertaken to slow
down and eventually control the epidemic worldwide spread of
KPC-Kp in health care institutions and the community. Anti-
biotic use policy and strict infection control measures are crit-
ical in the fight against carbapenemase-producing organisms.
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